Lifescience Podcast Series - Life Science Insights 360

Lifescience Insights 360

Exploring Innovation in Healthcare, Biotech & Medical Research

Join industry leaders, researchers, and innovators as they discuss the latest breakthroughs in life sciences. From AI-driven drug discovery to personalized medicine, dive deep into the topics shaping the future of healthcare.

About the Episode

A look back through the voices of our exceptional guests—visionary CEOs, founders, and innovators across life sciences, AI, biotech, and healthcare. Each conversation brought unique perspectives, real-world experiences, and valuable insights into the technologies and ideas shaping the future.

We’re grateful to every guest who shared their journey and expertise, making each episode truly meaningful. Thank you to our listeners for being part of this growing community and supporting these conversations.

As AI continues to accelerate innovation across industries, we remain committed to delivering deeper discussions, sharper insights, and more value-driven conversations that inspire innovation and impact.

Listen On

You can access The Lifescience podcast series on your favorite podcast platform by clicking on any of the icons below.

Have ideas for a podcast episode? Send your idea to our editorial team.

Explore All Seasons

Episode 23: Building A therapeutics platform from the Ground up| Dr.Stanley Lewis, CEO of A28 Therapeutics | E23

Precision Oncology and the Future of Targeted Cancer Therapies explores how innovative treatment approaches are reshaping modern oncology. highlights the potential of targeted oncolytic peptides (TOPs) and the importance of translating scientific discoveries into meaningful patient outcomes. Advanced therapeutic strategies can improve treatment precision, enhance quality of life, and support more personalized cancer care. The conversation also reflects on leadership, clinical innovation, and the challenges of bringing breakthrough therapies to market. Overall, it offers insight into the future of precision medicine and patient-centered biotech innovation.

Episode 22: Advancing the Future of Therapeutics | Ganesh Iyer, CEO & Founder, Opprtna Therapeutics

Aptamer Therapeutics and the Future of Precision Drug Discovery explores how next-generation therapeutic platforms are advancing treatment approaches for complex diseases. discusses the vision behind and the potential of aptamer-based therapeutics in addressing challenges across neurodegeneration and cancer. The conversation highlights the importance of innovative drug delivery, CNS targeting, and translating early-stage science into clinical-ready therapies. It also explores the realities of building a science-first biotech company, including partnerships, funding, and long-term strategic growth. Overall, the discussion offers valuable insight into the evolving future of precision medicine and modern drug discovery.

Episode 21: Innovation Infrastructure and Future of Synthetic Biology | Jodi Barrientos CEO, Ribbon Bio

Innovation Infrastructure and the Future of Synthetic Biology explores how advanced platforms enable faster biological design and development. Jodi Barrientos, CEO of Ribbon Bio, highlights the importance of scalable infrastructure for DNA synthesis and engineering. Strong foundations accelerate research, reduce costs, and improve reliability. It also supports breakthroughs in medicine, agriculture, and biotechnology. Overall, it shapes a future where synthetic biology can be developed efficiently and at scale.

Episode 20: Re-inventing Precision Medicine with AI | Jolly Nanda, Founder and CEO, Altheia, Inc

Re-inventing Precision Medicine with AI highlights how artificial intelligence is transforming personalized healthcare. Jolly Nanda, Founder and CEO of Altheia, Inc., emphasizes using data and machine learning to tailor treatments to individual patients. AI enables faster analysis of complex biological data for better decision-making. It improves diagnosis, treatment accuracy, and patient outcomes. Overall, it represents a shift toward more precise, data-driven medicine.

Episode 19: Future of Innovation and Ecosystem | James Zanewicz CEO, Connect

Future of Innovation and Ecosystem explores how collaboration and connected networks drive progress in life sciences. James Zanewicz, CEO of Connect, highlights the role of partnerships between startups, industry, and academia. Strong ecosystems enable faster innovation, resource sharing, and scaling of ideas. Technology and community together create new opportunities for growth. Overall, it shows how a well-connected ecosystem fuels sustainable innovation.

Episode 18: Re-Imagining Clinical Development Strategy|Suzanne Vyvoda Founder, CEO of Concordia BioStrategies

Re-Imagining Clinical Development Strategy focuses on transforming how clinical trials are designed and executed. Suzanne Vyvoda, Founder and CEO of Concordia BioStrategies, emphasizes smarter planning, patient-centric approaches, and adaptive trial models. The strategy leverages data and innovation to improve efficiency and reduce timelines. It also addresses regulatory complexities with more flexible frameworks. Overall, it aims to accelerate development while ensuring high-quality outcomes.

Episode 17: Driving Diversity in Clinical Research | Golda Naana Boakye CEO Naantu

Driving Diversity in Clinical Research highlights the need for inclusive and representative participation in clinical studies. Golda Naana Boakye, CEO of Naantu, emphasizes addressing gaps in underserved populations. Diverse data leads to more accurate and effective treatments for all communities. It also improves trust and engagement in healthcare systems. Overall, promoting diversity strengthens the quality and impact of clinical research.

Episode 16: How BioPharma Leaders Drive Growth | Ramani Varanasi, Founder and CEO, ReVive Advisors

How BioPharma Leaders Drive Growth explores the strategies behind scaling success in the biopharma industry. Ramani Varanasi, Founder and CEO of ReVive Advisors, highlights the importance of innovation, strategic partnerships, and market alignment. Leaders focus on balancing scientific advancement with strong business execution. Data-driven decisions and regulatory awareness play a key role in sustainable growth. Overall, it shows how effective leadership drives long-term value in biopharma.

Episode 15: Exploring Scientific Innovation | Dr. Dirk Heckel, CTO at Siemens Healthineers

Exploring Scientific Innovation highlights how advanced technology is driving progress in healthcare and research. Dr. Dirk Heckel, CTO at Siemens Healthineers, emphasizes the role of AI, imaging, and digital solutions in improving diagnostics and treatment. The focus is on making healthcare more precise, efficient, and accessible. Innovation enables faster insights and better patient outcomes. Overall, it reflects a future where science and technology work together to transform care.

Episode 14: Lab Bench to Boardroom: Leading Science-Driven Innovation | Ashley Zehnder, CEO, Fauna Bio

Lab Bench to Boardroom focuses on transforming scientific discoveries into real-world business impact. Ashley Zehnder, CEO of Fauna Bio, highlights the importance of combining deep science with strong leadership and strategy. It emphasizes bridging the gap between research and commercialization. The approach encourages data-driven decision-making and innovation. Overall, it showcases how science-led companies can drive meaningful advancements in healthcare.

Episode 13: Pharma Frameworks: From Strategy to Safety | Alan White, CEO of Arriello

Pharma Frameworks: From Strategy to Safety highlights how structured approaches guide pharmaceutical development end-to-end. Alan White, CEO of Arriello, emphasizes aligning business strategy with regulatory compliance and patient safety. The framework supports efficient drug development while meeting global standards. It also strengthens risk management and quality assurance processes. Overall, it ensures that innovation is delivered safely, effectively, and responsibly.

Episode 12: Make clinical, regulatory, and medical research 10X faster | Michelle Wu , CEO of NyquistAI

Michelle Wu, CEO of NyquistAI, focuses on accelerating clinical, regulatory, and medical research by 10X using advanced technology. Her approach leverages AI and automation to reduce manual effort and speed up data analysis. It aims to streamline clinical trials and regulatory approvals with greater accuracy. By integrating intelligent systems, research processes become more efficient and scalable. This transformation helps bring new treatments to market faster. Overall, her vision is to modernize healthcare research through innovation and speed.

Episode 11: Transforming Life Sciences Workflows with AI Platforms | Ome Ogbru, CEO of AINGENS

Inside Bio-IT World focuses on how technology is revolutionizing life sciences. It combines biology with tools like AI, big data, and bioinformatics to speed up research and innovation. These technologies help in drug discovery, genomics, and personalized medicine. It also improves clinical processes and decision-making. Overall, Bio-IT is shaping a smarter, faster future for healthcare and scientific research.

Episode 10 : Bioinformatics & Data Analysis: Speeding Up Research to Save Time & Cost | Aman Agarwal

In this episode of Life Science Insights 360, we speak with Aman Agarwal, CEO of Novaflow, about the challenges and opportunities in bioinformatics and data analysis for life sciences research. Aman discusses how traditional bioinformatics workflows can take weeks or months, making experiments expensive and limiting scientific progress due to the high cost and limited availability of skilled bioinformaticians. He shares insights into how AI-driven solutions are helping researchers accelerate analysis, reduce costs, and make data-driven decisions faster, transforming the pace of discovery in biotech and pharma.

Episode 9 : Building & Scaling Biotech Startups | Rachel Reboulet, Founder of Streamline BioOps

What does it take to turn a groundbreaking biotech idea into a scalable, successful company? In this episode, we sit down with Rachel Reboulet, Founder and Biotech Ops Partner at Streamline BioOps, to explore the dynamic world of life science startups. With deep, hands-on experience guiding companies from Seed to Series B, Rachel shares how she helps founders establish solid operational frameworks, navigate growth challenges, and accelerate progress from lab to market. The conversation uncovers the key ingredients of building resilient biotech ventures — from strategic planning and team alignment to operational excellence. Tune in to learn how Streamline BioOps empowers startups to scale smarter and thrive in the competitive biotech landscape.

Episode 8 : Driving Data-Driven Precision in Healthcare | Jamie Littlejohns, CEO, Velsera

What if healthcare data could transform from scattered information into lifesaving intelligence? In this episode, we sit down with Jamie Littlejohns, CEO of Velsera, to unpack the future of data-driven and precision healthcare. Jamie shares how Velsera is closing the gap between raw biomedical data and actionable clinical insights—empowering researchers, clinicians, and healthcare organizations to make faster, smarter, and more personalized decisions.

Episode 7 : Strategic Innovation in Life Sciences | Dr. Amandeep SIngh, Ph.D., Strategy Consultant

What happens when scientific expertise meets strategic insight? In this episode, we sit down with Dr. Amandeep Singh, Ph.D., a seasoned strategy consultant who seamlessly bridges the gap between academic research and real-world business transformation in the life sciences industry. Together, we explore how Dr. Singh combines scientific rigor with strategic frameworks to help pharmaceutical and biotech companies drive meaningful innovation.

Episode 6 : Unlocking the Power of Omics in Modern Healthcare | Prabhu Mathiyalagan, CEO of Benthos

What if the key to the future of healthcare lies hidden within our molecular data? In this episode, we sit down with Prabhu Mathiyalagan, CEO of Benthos, to explore the revolutionary world of multi-omics—spanning genomics, proteomics, metabolomics, and beyond. Prabhu unpacks how these powerful layers of biological insight are transforming the way we understand disease, design therapies, and deliver personalized care.

Episode 5: Global Access & Innovation in Life Science | Poojan Suri, CEO, Garner BioSolutions

What if biotech innovation knew no boundaries? In this episode, we sit down with Poojan Suri, CEO of Garner BioSolutions, to discuss how the company is redefining the future of biotechnology through global access, decentralized R&D, and collaborative innovation. Poojan shares his bold vision for a borderless life sciences ecosystem—one where scientific progress and patient impact extend far beyond traditional limits.

Episode 4: Unlocking Genomic Insights: Real-World Data in Action | Dr. Leeland Ekstrom | CEO, NashBio

What if the key to the next medical breakthrough lies in the data all around us? 💡 In this episode, we sit down with Dr. Leeland Bekstrom, CEO of NashBio, to explore how real-world clinical and genomic data is revolutionizing genomics and precision medicine. Dr. Bekstrom discusses how harnessing population-scale datasets is enabling faster discoveries, more personalized treatments, and meaningful progress in health equity.

Episode 3 : AI in Drug Discovery | Douglas Selinger, Founder & CEO, Plex Research

How is AI revolutionizing drug discovery and shaping the future of medicine?
In this episode of LifeScience Podcast 360, we sit down with Douglas Selinger, Founder and CEO of Plex Research, to explore how artificial intelligence is accelerating biomedical innovation—from molecule to medicine.
Discover how AI is transforming the pharmaceutical pipeline, enabling faster, more precise, and cost-effective drug development. We dive into real-world applications, key technologies, and the potential impact on patients, researchers, and the life sciences industry as a whole.

Episode 2 : Nordic Edge: Global Influence in Healthcare & Beyond | Mary Siroris, Nordic Global

What makes the Nordic region a powerhouse for innovation, sustainability, and global impact? In this episode, we sit down with Mary Siroris, Managing Director of Nordic Global, to explore how Nordic countries are shaping the future of life sciences and sustainable innovation. Mary offers a behind-the-scenes look at the Nordic model—a blend of collaboration, ethics, and forward-thinking policies that’s redefining healthcare, biotech, and digital health worldwide.

Episode 1 : Inside Bio-IT World: Technology Driving the Future of Life Sciences

Inside Bio-IT World explores how cutting-edge technology is transforming life sciences and healthcare. It highlights the role of bioinformatics, AI, and big data in accelerating drug discovery and precision medicine. The field connects biology with advanced computing to analyze complex biological systems efficiently. Innovations like genomics, cloud computing, and machine learning are enabling faster and more accurate research outcomes. Bio-IT is also improving clinical trials, diagnostics, and personalized treatment strategies.

Episode 1: Transforming Scientific Documents with AI | Levi S. Lian | CEO & Founder, Raycaster

Document Intelligence and the Future of Enterprise AI explores how artificial intelligence is reshaping the way organizations manage and understand complex information. shares the vision behind and explains why solving the challenge of unstructured documents is becoming essential for modern enterprises. The conversation highlights the evolution of AI beyond traditional OCR and automation toward true document intelligence that can improve compliance, extract meaningful insights, and support faster decision-making. It also explores enterprise adoption, data security, and the growing role of AI-powered knowledge work in the future of business operations.

Key Insights

Transforming Clinical Trials

Learn how AI is optimizing patient recruitment, monitoring trial progress in real-time, and identifying potential safety signals earlier, making clinical trials more efficient and cost-effective.

Automating Regulatory Documentation

Discover AI-powered solutions that streamline the creation and submission of regulatory documents, reducing approval timelines while maintaining compliance with global standards.

Accelerating Drug Development

Explore how intelligent algorithms are identifying promising drug candidates faster, predicting clinical outcomes, and helping bring safe, effective treatments to market in record time.

Stay Ahead of AI in Healthcare

Subscribe for Future Episodes